Results 81 to 90 of about 275,152 (253)

Integrative Multi-Omics and Experimental Analyses Identify TAPBP as a Key Mediator Linking Genetic Susceptibility to Melanocyte Dysfunction in Vitiligo

Clinical, Cosmetic and Investigational Dermatology
Jinlong Shi,1,* Mingzhen Guo,2,* Liying Fu,1 Jiangman He,1 Yuan Hu3 1Department of Dermatology, Zhengzhou People’s Hospital, Zhengzhou, Henan, People’s Republic of China; 2Department of Laboratory, Women and Children’s Hospital Affiliated
Shi J, Guo M, Fu L, He J, Hu Y
doaj  

Nationwide Temporal Trends in Adverse Pregnancy Outcomes and Treatments in Systemic Lupus Erythematosus Pregnancy Over Two Decades in Sweden

Arthritis &Rheumatology, EarlyView.
Objective This nationwide descriptive study examined temporal trends in adverse pregnancy outcomes (APOs) and treatments in systemic lupus erythematosus (SLE) pregnancies in Sweden over 2003 to 2022. Methods Using nationwide Swedish registers, we identified 1,417 pregnancies of women with prevalent SLE and delivery dates in 2003 to 2022 and matched ...
Ngoc V. Nguyen, Anna Sandström, Annica Dominicus, Elisabet Svenungsson, Karin Hellgren, Julia F. Simard, Elizabeth V. Arkema   +6 more
wiley   +1 more source

Hyaluronic Acid Filler CPM-V ± Lidocaine for Chin Augmentation: A Randomized, Multicenter, Open-Label Post-Market Follow-Up Study

Clinical, Cosmetic and Investigational Dermatology
Tatjana Pavicic,1 Martina Kerscher,2 Sonja Sattler,3,4 Welf Prager,5 Ulrich Kühne,6 Ernst Magnus Noah,7 Eva Kristina Bee,8 Rodrigo da Mota,9 Michael Sebastian,10 Peter Arne Gerber,11,12 YingJu Tseng,13 Christian Carreon,14 Tanja C Fischer15 1Private ...
Pavicic T, Kerscher M, Sattler S, Prager W, Kühne U, Noah EM, Bee EK, da Mota R, Sebastian M, Gerber PA, Tseng Y, Carreon C, Fischer TC   +12 more
doaj  

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

Arthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

A Deep Learning-Based Automated Scoring System for Predicting Eyelid Rejuvenation Outcomes After Monopolar Radiofrequency Treatment

Clinical, Cosmetic and Investigational Dermatology
Dong Hye Suh,1 Sang Jun Lee,1 In Yong Kim,2 Byung Chul Jang,3 Hei Sung Kim4 1ArumdaunNara Dermatologic Clinic, Seoul, Korea; 2Switz Dermatologic Clinic, Seoul, Korea; 3School of Electronics and Electrical Engineering, Kyungpook National University, Daegu,
Suh DH, Lee SJ, Kim IY, Jang BC, Kim HS
doaj  

Correction to “Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors”

Advanced Science, EarlyView.
wiley   +1 more source

TWEAK/Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays

Arthritis &Rheumatology, EarlyView.
Objective Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus‐associated cardiac injury is unclear. We investigated the role of TWEAK/fibroblast growth factor–inducible 14 (Fn14) signaling in SLE‐related ...
Yale Liu, Zhu Yan, Xueting Peng, Meixuan Li, Juan Wang, Yan Zhang, Xiaoqian Hu, Mingzhu Zhou, Kaixuan Ren, Dan Zhang, Xingyi Guo, Yumin Xia, Huanhuan Huo   +12 more
wiley   +1 more source

Evaluation of the Effect of Laterality and Age on Pain Perception in Monopolar Radiofrequency Facial Therapy

Clinical, Cosmetic and Investigational Dermatology
Ying Wang,* Han Bai,* Congqi Shi, Meng Wang, Shasha Zhao, Xiaodong Lai, Yan Yan Department of Dermatology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100144, People’s Republic ...
Wang Y, Bai H, Shi C, Wang M, Zhao S, Lai X, Yan Y   +6 more
doaj  

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

Arthritis &Rheumatology, EarlyView.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola, Philip Mease, Alan Kivitz, Naveed Sattar, Laura C. Coates, Daniel Aletaha, Cynthia E. Kartman, Peter Fischer, Luna Sun, Píndaro Martínez‐Osuna, Andris Kronbergs, Purvi Prajapati, Anabela Cardoso, Mark C. Genovese, Alexis Ogdie   +14 more
wiley   +1 more source

Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources

Clinical, Cosmetic and Investigational Dermatology
Mohammed A Al Ameer,1 Abdulaziz T Alnajim,1 Ali Al Ameer,2 Zainab Alsalman,3 Ghadeer A Al Ameer,4 Sarah T Alnajim,5 Anwar A Alghamdi,1 Raniya Moideen,4 Enas M Al Hadi6 1Department of Dermatology, Aseer Central Hospital, Abha, Saudi Arabia; 2Department of
Al Ameer MA, Alnajim AT, Al Ameer A, Alsalman Z, Al Ameer GA, Alnajim ST, Alghamdi AA, Moideen R, Al Hadi EM   +8 more
doaj